Regenerative technology to restore and preserve erectile function in men following prostate cancer treatment: evidence for penile rehabilitation in the context of prostate cancer survivorship

被引:4
作者
Chung, Eric [1 ,2 ,3 ]
机构
[1] AndroUrol Ctr, Suite 3,530 Boundary St, Brisbane, Qld 4000, Australia
[2] Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld, Australia
[3] Macquarie Univ Hosp, Sydney, NSW, Australia
关键词
ejaculation; erectile dysfunction; erectile function; orgasm; salvage radiation therapy; salvage radical prostatectomy; sexual desire; sexual function; sexual rehabilitation; sexuality; EXTRACORPOREAL SHOCKWAVE THERAPY; PLATELET-RICH PLASMA; STEM-CELL THERAPY; RADICAL PROSTATECTOMY; WAVE THERAPY; GROWTH-FACTOR; GENE-TRANSFER; RAT MODEL; DYSFUNCTION; SAFETY;
D O I
10.1177/17562872211026421
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Erectile dysfunction (ED) following prostate cancer treatment is not uncommon and penile rehabilitation is considered the standard of care in prostate cancer survivorship (PCS), where both patient and his partner desire to maintain and/or recover pre-treatment erectile function (EF). There is a clinical interest in the role of regenerative therapy to restore EF, since existing ED treatments do not always achieve adequate results. Aim: To review regenerative therapies for the treatment of ED in the context of PCS. Materials and Methods: A review of the existing PubMed literature on low-intensity extracorporeal shockwave therapy (LIESWT), stem cell therapy (SCT), platelet-rich plasma (PRP), gene therapy, and nerve graft/neurorrhaphy in the treatment of ED and penile rehabilitation, was undertaken. Results: IESWT promotes neovascularization and neuroprotection in men with ED. While several systematic reviews and meta-analyses showed positive benefits, there is limited published clinical data in men following radical prostatectomy. Cellular-based technology such as SCT and PRP promotes cellular proliferation and the secretion of various growth factors to repair damaged tissues, especially in preclinical studies. However, longer-term clinical outcomes and concerns regarding bioethical and regulatory frameworks need to be addressed. Data on gene therapy in post-prostatectomy ED men are lacking; further clinical studies are required to investigate the optimal use of growth factors and the safest vector delivery system. Conceptually interpositional cavernous nerve grafting and penile re-innervation technique using a somatic-to-autonomic neurorrhaphy are attractive, but issues relating to surgical technique and potential for neural 'regeneration' are questionable. Conclusion: In contrast to the existing treatment regime, regenerative ED technology aspires to promote endothelial revascularization and neuro-regeneration. Nevertheless, there remain considerable issues related to these regenerative technologies and techniques, with limited data on longer-term efficacy and safety records. Further research is necessary to define the role of these alternative therapies in the treatment of ED in the context of penile rehabilitation and PCS.
引用
收藏
页数:10
相关论文
共 65 条
[1]   Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible [J].
Anastasiadis, AG ;
Benson, MC ;
Rosenwasser, MP ;
Salomon, L ;
El-Rashidy, H ;
Ghafar, MA ;
McKiernan, JM ;
Burchardt, M ;
Shabsigh, R .
PROSTATE CANCER AND PROSTATIC DISEASES, 2003, 6 (01) :56-60
[2]   The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial [J].
Baccaglini, Willy ;
Pazeto, Cristiano Linck ;
Correa Barros, Eduardo Augusto ;
Timoteo, Frederico ;
Monteiro, Leonardo ;
Saad Rached, Raiff Yusser ;
Navas, Arthur ;
Glina, Sidney .
JOURNAL OF SEXUAL MEDICINE, 2020, 17 (04) :688-694
[3]  
Bahk JY, 2010, EXP CLIN TRANSPLANT, V8, P150
[4]   Meta-analysis of randomized controlled trials that assess the efficacy of low-intensity shockwave therapy for the treatment of erectile dysfunction [J].
Campbell, Jeffrey D. ;
Trock, Bruce J. ;
Oppenheim, Adam R. ;
Anusionwu, Ifeanyichukwu ;
Gor, Ronak A. ;
Burnett, Arthur L. .
THERAPEUTIC ADVANCES IN UROLOGY, 2019, 11 :1-13
[5]   Low-Intensity Shock Wave Therapy in Sexual Medicine-Clinical Recommendations from the European Society of Sexual Medicine (ESSM) [J].
Capogrosso, Paolo ;
Frey, Anders ;
Jensen, Christian Fuglesang S. ;
Rastrelli, Giulia ;
Russo, Giorgio I. ;
Torremade, Josep ;
Albersen, Maarten ;
Gruenwald, Ilan ;
Reisman, Yacov ;
Corona, Giovanni .
JOURNAL OF SEXUAL MEDICINE, 2019, 16 (10) :1490-1505
[6]   The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model of neurogenic impotence [J].
Chen, KC ;
Minor, TX ;
Rahman, NU ;
Ho, HC ;
Nunes, L ;
Lue, TF .
BJU INTERNATIONAL, 2005, 95 (07) :1077-1080
[7]  
Chung E, 2017, EXPERT REV QUAL LIFE, V2, P279
[8]   Clinical Practice Guideline Recommendation on the Use of Low Intensity Extracorporeal Shock Wave Therapy and Low Intensity Pulsed Ultrasound Shock Wave Therapy to Treat Erectile Dysfunction: The Asia-Pacific Society for Sexual Medicine Position Statement [J].
Chung, Eric ;
Lee, Joe ;
Liu, Chia Chu ;
Taniguchi, Hisanori ;
Zhou, Hui Liang ;
Park, Hyun Jun .
WORLD JOURNAL OF MENS HEALTH, 2021, 39 (01) :1-8
[9]   A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction [J].
Chung, Eric ;
Wang, Juan .
EXPERT REVIEW OF MEDICAL DEVICES, 2017, 14 (12) :929-934